Fifty-five years of Breakthroughs

Garvan research has played a major role in saving lives and changing the health of generations.  Scroll down to discover some of the key advances we've made over the last 55 years.

 

 

2018

Found: a new form of DNA in our cells

We discovered a new form of DNA called the ‘i-motif’ to be located inside human cells.

Learn more
2017

MRI screens pick up early stage cancers

Our research, along with international efforts, showed that whole-body MRI screening can detect primary tumours throughout the body, at a curable stage, in people with high genetic risk of cancer.

Learn More
2016

Launch of whole genome sequencing service

We launched Australia’s first clinical whole-genome sequencing service, tripling diagnostic rates for people living with rare and genetic conditions.

Learn More
2015

Genomic diagnosis changes lives

Using whole genome sequencing, we diagnosed a previously mysterious immune disorder in a critically ill 5-year-old boy. Armed with this knowledge, clinicians changed Alan's treatment – radically improving his health and his outlook.

Learn More
2014

A key to creating blood stem cells in the laboratory

We uncovered a mechanism essential for forming hematopoietic stem cells – a key step toward generating them in the laboratory as treatment for a wide range of diseases, including cancers and other disorders of the blood and immune system.

Read more
2013

Nanotechnology for pancreatic cancer

With colleagues in the UK, we developed an imaging method to monitor areas deep within pancreatic tumours and revealed a new way to improve drug delivery.

Read more
2012

Unmasking the secrets of pancreatic cancer

We sequenced the genomes of 100 pancreatic tumours and identified new mutations that lead to pancreatic cancer.

Learn More
2011

Breakthrough study links Type 1 diabetes and Sjögren's syndrome

With collaborators, we discovered a new group of immune cells that for the first time directly link two autoimmune diseases, Type 1 diabetes and Sjögren's syndrome.

Read more
2010

Gene silencing common in cancers

A group of Garvan scientists discover that extensive gene silencing is common in cancer, with up to 3% of the genome affected by epigenetic changes to DNA in cancer cells.

Learn More
2009

Our brains build bones

We showed that the brain, through the hormone NPY, helps control the building of our skeletons.

LEARN MORE
2000

Belly fat link to diabetes

We uncovered the role of abdominal fat in determining risk of type 2 diabetes.

LEARN MORE (.PDF)
1999 to 2005

Growing nerve cells

We developed methods to culture adult nerve stem cells capable of generating new brain cells, giving hope that some neurodegenerative diseases could be reversed.

LEARN MORE
1993

Cyclins drive the progression of breast cancer

We made one of the decade’s most significant advances in breast cancer when we discovered the role of proteins called cyclins.

Back to top
1987

Genes contribute to bone health

We helped discover the first genetic factors that impact bone density of the spine and the proximal femur in adults.

Read more
1973

Lifesaving insulin infusions

We developed an infusion technique that treats ketoacidosis, a potentially life-threatening complication associated with diabetes.

LEARN MORE
1965

Measuring growth hormone

We developed an Australian-first ‘radioimmunoassay’ technique to measure growth hormone in people.

Back to top